Peak HumanDatabase
    All Research
    PAPER GGT-CAMeta-Analysis2017

    Gamma-Glutamyltransferase and Risk of Cardiovascular Mortality: A Dose-Response Meta-Analysis of Prospective Cohort Studies

    Dose-response meta-analysis of nine prospective cohorts (>500,000 participants) showing a graded increase in cardiovascular mortality risk with rising GGT.

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    PLOS ONE

    Feb 2017

    03

    Structured Methods

    Study Design
    Meta-Analysis
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2017). Gamma-Glutamyltransferase and Risk of Cardiovascular Mortality: A Dose-Response Meta-Analysis of Prospective Cohort Studies. PLOS ONE. https://doi.org/10.1371/journal.pone.0172631

    DOI

    10.1371/journal.pone.0172631

    PubMed

    28231268

    Source

    Publisher

    Journal

    PLOS ONE

    05

    Indexing

    Biomarkers

    ggt
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation
    See your Peak Human Score How it works